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Background
There is growing evidence that HIV-infected adults receiving antiretroviral therapy (ART)
in sub-Saharan Africa experience a restoration in their economic outcomes following ART
initiation [1–6]. However, the socio-economic status of most patients and their households
has been very poor at the time of ART initiation, suggesting that it may be possible to avert
an economic decline if treatment were initiated earlier.
Along with important new evidence on the direct medical benefits to individual patients as
well the secondary preventive benefits from early ART initiation [7], preventing the
degradation of a household’s or an individual’s economic profile may be an additional
benefit that has not been carefully examined. The size of such benefits depends on the nature
of the association between socio-economic outcomes and CD4+ T-cell counts among HIV-
infected individuals, and whether the outcomes at CD4 ranges that are above current
treatment initiation thresholds.
Several studies conducted in sub-Saharan Africa have documented the harmful effects of
HIV/AIDS on socio-economic outcomes of individuals and households. Some of these
studies have examined the household-level consequences of adult mortality due to HIV/
AIDS [8, 9], whereas others have employed cross-sectional data to describe socio-economic
characteristics of HIV-infected individuals and to compare them to HIV-uninfected
individuals and their households [10]. A few studies have also used longitudinal or
retrospective data to examine how socio-economic outcomes change as a result of HIV
disease progression [11, 12]. However, many subjects in these studies had advanced HIV
infection from the outset, and the studies lacked data on the CD4 count of subjects from the
time of infection, thus resulting in a gap in knowledge about employment patterns at earlier,
higher CD4 count stages of HIV infection. To overcome this gap, there is a need to conduct
population-based studies that obtain data on CD4 cell counts and economic outcomes, while
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also identifying persons infected with HIV before they present to care for symptomatic
disease and or exhibit CD4+ T-cell decline. This would further our understanding of the full
spectrum of the economic effects of early and delayed treatment of HIV.
We sought to examine the association between HIV infection, CD4 cell count and
socioeconomic outcomes among adults who participated in a community-wide health
campaign aimed at determining HIV status among all community members in a rural parish
in Uganda. Data collected during and after the campaign were used to examine adult
employment and child schooling outcomes.
Methods
Socio-economic data were collected during a community health campaign in rural Uganda
and during a household socio-economic survey conducted among a sample of campaign
participants.
Community health campaign
Over a 5-day period in May 2011, a community-wide health campaign that offered HIV
testing and other health services was conducted in Kakyerere parish in Mbarara District,
Uganda. All individuals residing in the Parish were offered the opportunity to come to one
of three locations where rapid HIV testing and other communicable and non-communicable
disease screening was provided. HIV-infected adults not already receiving care were linked
to care (including ART) at nearby health facilities. Details on the campaign and health
outcomes of participants have been reported previously [13]. Point-of-care CD4+ T cell
count testing (PIMA, Alere) was performed on all HIV+ persons. During the campaign,
trained counselors also collected information on the demographic characteristics, health
behavior, and employment outcomes of participants.
Household socio-economic survey
Following completion of HIV testing, all HIV-infected adult participants and a random
sample of HIV-uninfected adult participants (those whose campaign ID ended in “0” or “5”)
were asked if they would be willing to participate in a socio-economic survey that would
take place at their home in subsequent weeks. Participants were not included in the survey if
they resided outside Kakyerere parish. Participants who provided written consent during the
campaign were asked to provide contact information including their name, phone number,
and location of residence. The household socio-economic survey consisted of several
modules that sought information on demographic characteristics of the participants’
household, employment outcomes of household members above the age of 12 years, durable
goods and livestock owned by household, cash and in-kind transfers sent or received by the
household, and education of household members between the ages of 6–25 years of age. The
survey was based on World Bank Living Standards Measurement Surveys[14] and adapted
to the study setting. The household survey was conducted by trained interviewers who
visited the homes of selected participants between June 13, 2011 and August 13, 2011.
Health and demographic information collected from the participants during the community
health campaign was linked to the household socio-economic survey data by the
participants’ unique community health campaign identification number.
Statistical analyses
Employment outcomes of adults (age ≥18 years) were measured by two continuous
variables that were recorded during the campaign: the number of days that a person had
worked during the past month and the number of hours that a person reported working on a
typical day during the past week. These measures sought to record income-generating work
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performed on the farm belonging to one’s household, in a household business or enterprise,
and for a wage or salary. School enrollment of children between the ages of 6–18 years were
recorded in the household survey and was represented by a binary variable indicating
whether the person was enrolled in school. Two measures that represented the health status
of HIV-infected adult participants were used: CD4+ T-cell count and ART status. The CD4
count was defined as a continuous variable as well as a categorical variable with four
categories when using the community health campaign data (CD4≥500, CD4 350–499, CD4
200–349, and CD4<200); these categories were chosen to reflect the various ART initiation
thresholds that have been recommended by the WHO or used in Uganda and the US [15,
16]. When using the household survey data that contained fewer observations, CD4 count
was defined as a binary variable (CD4≥350 and CD4<350, based on the ART initiation
threshold in Uganda) since the statistical power to compare outcomes in the four CD4
categories above was limited.
Least squares regression analysis was used to examine the association between CD4 count
and employment outcomes of HIV-infected adult participants, adjusting for age, age squared
(in order to capture non-linear effects of age), sex (binary indicator variable equal to 1 if the
person was female), interactions between age and sex (to allow the age-employment
association to differ by gender), and ART status. Regressions were also performed
separately for the sample of HIV-infected adult participants on ART and not on ART. In the
regression models that contained four different CD4 categories, CD4<200 served as the
reference group. Post-estimation Wald tests were performed the following hypotheses about
the coefficients of the CD4 categories: CD4 350–499 = CD4 200–349; CD4≥500 = CD4
200–349; CD4≥500 = CD4 350–499; For adults not on ART, a kernel-weighted local
polynomial regression (with zero degree polynomials) was also performed to examine the
association between employment outcomes and CD4 count in a flexible, nonparametric
form. Finally, to examine the association between children’s school enrollment and CD4
count of HIV-infected adults, a probit model was estimated with age, age squared, and sex
included as controls and marginal effects were calculated. All statistical analyses were
performed using Stata/SE 12.1 (StataCorp, College Station, Texas, USA).
Ethical considerations
The Makerere University School of Medicine Research and Ethics Committee, the Ugandan
National Council on Science and Technology, and the UCSF Committee on Human
Research approved the study.
Results
During the five-day community health campaign, 2,323 adults attended one of the three sites
within the parish. Based on census estimates provided by the Ugandan Bureau of Statistics,
approximately 74% of adults in the community participated in the health campaign (95% of
women and 52% of men). Overall, 2,282/2,323 adults were tested for HIV, and 179/2,282
(7.8%) tested positive. A CD4 count was successfully measured for 168/179 HIV-infected
adults.
For the household survey, 302 HIV-uninfected participants and 90 HIV-infected participants
were consented at the time of the campaign. A substantial number of HIV-infected
participants were not consented for the household survey due to logistical problems during
the first day of the one-week campaign and residence outside of the parish. HIV-infected
participants who were consented had similar characteristics as those who were not consented
(72% and 80% female, 32.5 and 33.6 years of age, CD4 cell count 455 and 447,
respectively). Among those who provided consent, household survey interviews were
conducted at 339 households (86.4%). Reasons for non-completion of 53 surveys included
THIRUMURTHY et al. Page 3













an incorrect or inaccurate address (31), relocation since the time of the campaign (14), and
not being able to find a participant at home (8).
Demographic characteristics
Demographic and other socio-economic characteristics of participants in the community
health campaign and in the household survey are described in Table 1. Compared to HIV-
uninfected participants, HIV-infected campaign participants were significantly more likely
to be female and less likely to be married. They were also significantly younger and came
from households that were smaller in size. No significant differences were found in
educational attainment of the adult participants. Households of HIV-infected adults
generally had lower wealth (measured by land and livestock holdings) than those of HIV-
uninfected adults. Among HIV-infected adults, the median CD4 count was 416 (IQR: 283–
568) and 37% were receiving ART.
Adult employment outcomes and children’s school enrollment
Table 2 shows the mean employment of campaign participants and education levels of
children in the households that were part of the household survey. HIV-infected participants
with CD4<200 and CD4 200–349 worked fewer days in the past month than both HIV-
uninfected participants and HIV-infected participants with CD4 350–499 and ≥500 (17.9
and 20.3 days compared to 23.3 and 22.7 days, respectively). The number of hours worked
on a typical day in the past week, however, was lowest among those with CD4<200 (5.5
hours) but higher and roughly similar among those in the higher CD4 categories. In
households of HIV-uninfected adults, school enrollment rates were 97.2% and 84.8% among
children 6–11 and 12–18 years of age, respectively. In households of HIV-infected
participants with CD4<350 and CD4≥350, enrollment rates of children 6–11 years of age
were 95% and 96.6% respectively. Among children 12–18 years of age, however,
enrollment rates were lower in households of adults with CD4<350 (75.0%) than in
households with corresponding CD4≥350 (87.0%).
Association between employment outcomes and CD4 count
After adjusting for age and sex, a higher CD4 count was associated with more days worked
in the past month (0.60 more days per 100 cells/μL; column 1 of Table 3). In results not
reported, the square of the CD4 cell count was included in the regression model and not
found to be statistically significant. Compared to the reference group of participants with
CD4<200, those with CD4 350–499 and ≥500 worked 6.04 and 5.97 more days in the past
month, respectively (p<0.01 for both coefficients; column 2). Given the number of days
worked by those with CD4<200 (17.9), these results imply that participants with CD4 350–
499 and CD4≥500 worked 34% and 33% more, respectively. We observed no significant
difference in days worked/month by participants with CD4 200–349 compared to CD4<200.
The association between CD4 and employment remained intact even after controlling for
whether participants were on ART (column 3). The number of days worked in the past
month by those on ART was not significantly different from days worked by those not on
ART. Importantly, post-estimation Wald tests did not reject the hypothesis that the
coefficients for CD4≥500 and CD4 350–499 were identical (p=0.97 and p=0.85 in columns
2 and 3). However, the p-values were considerably smaller for the tests of the hypotheses
that the coefficients of CD4≥500 and CD4 350–499 were equal to the coefficient of CD4
200–349, suggesting that these higher CD4 groups worked substantially more than those
with CD4<200 as well CD4 200–349.
For the second employment measure, hours worked/day, columns 4–6 of Table 4 show a
largely similar association with CD4 count. After adjusting for age and sex, a higher CD4
count was associated with more hours worked but the effect was not statistically significant.
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Participants with CD4≥500 worked 2.1 hours/day more than those with CD4<200 (p<0.05),
or 38% more hours/day than the reference group. Those with CD4 200–349 worked 2.1
hours/day more than those with CD4≤200 (p<0.05), but no such effect was found for those
with CD4 350–499. These results persisted even after controlling for receipt of ART
(column 6).
Employment and CD4 count association among those on ART and not on ART
Figure 1 shows the results of a nonparametric regression that estimates the association
between days worked in the past month and CD4 count among adults not on ART, without
adjustment for other characteristics. Higher CD4 counts are associated with more days
worked/month, with a difference of more than 10 days between the low and high end of the
CD4 distribution. Table 4 shows the results of estimating the main regression model
separately for those on ART and not on ART. Among those not on ART, participants with
CD4 above 350 cells/μL had the best employment outcomes (columns 1 and 3, Table 4).
Participants with CD4≥500 worked 6.9 days/month and 2.5 hours/day more than those with
CD4<200 (p<0.01 and p<0.05, respectively). Given the mean employment for those with
CD4<200 and not on ART, these effects represent differences of 39% (6.9/17.7) and 44%
(2.5/5.7) respectively. Those with CD4 350–499 worked 5.8 days/month more than those
with CD4<200 (p<0.05) but not significantly more hours/day. However, when comparing
the effects for the various CD4 categories, we could not reject the hypotheses that (a) the
coefficients for CD4≥500 and CD4 350–499 were identical to that for CD4 200–349; and
(b) that the coefficients for CD4≥500 and CD4 340–499 were identical.
Among those on ART, the biggest differences in days worked/month were found between
participants with CD4 350–499 and CD4<200 (difference of 6.9 days, p<0.10). For hours
worked on a typical day in the past week, the comparison between those with CD4 200–349
and CD4 ≤200 revealed the largest difference (2.3 hours, p<0.10). Differences between the
high CD4 categories were not significant, as indicated by the post-estimation hypothesis
tests.
Association between children’s school enrollment and CD4 count
Table 5 shows that an increase of 100 cells/μL in adult CD4 count was associated with 1
percent increase in the probability that a child in the adult’s household was enrolled in
school, but this association was not significant (column 1). Children in households of adults
with CD4≥350 had a 7% higher probability of being enrolled in school than children in the
reference group of households with adult CD4<350 (column 2). The school enrollment
differences between high and low CD4 count households were especially large among
children between 12–18 years of age (columns 4): those in high CD4 households had a 10%
higher probability of being enrolled in school than those in low CD4 households. However,
the school enrollment differences between high and low CD4 households were not
statistically significant.
Discussion
Our multi-disease community health campaign in rural southwestern Uganda provided an
opportunity to study the association between socio-economic outcomes and health status
among a population that includes HIV-infected adults who were previously undiagnosed and
had higher CD4 counts than would normally be observed in a clinic-based population. We
were therefore able to compare employment and household-level education outcomes of
HIV-infected adults with high CD4 counts to those with low CD4 counts. Among HIV-
infected adults not on ART, we found an especially strong association between employment
outcomes and CD4 count. Participants with CD4≥500 worked nearly one full week more per
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month and 44% more hours per day than those with CD4<200. Those with CD4 350–499
also worked significantly more days than those with CD4<200. These findings raise the
possibility that ART initiation at CD4 counts of 350 or further above could prevent a decline
in economic status and enable HIV-infected adults to work just as much as their HIV-
uninfected peers.
An important advantage of this study is that by conducting a community-wide health
campaign, we were able to examine the association between socio-economic outcomes and
CD4 count over a larger range of CD4 counts and disease stages than in previous studies [2,
3]. Clinic-based longitudinal studies are useful for assessing the effect of ART on
employment outcomes, but in many cases patients are enrolled with low CD4 counts or
shortly before ART initiation. Along with poor immunologic status, they have low
socioeconomic status and high food insecurity at the outset. In our study, among HIV-
infected adults not on ART, those with the highest CD4 counts (CD4 350–499 and
CD4≥500) worked considerably more than those with CD4 200–349 and CD4<200.
However, due to the small sample size of HIV-positive participants in our study,
employment differences between those with CD4≥500 and CD4 350–499 were not
statistically significant.
We also found a positive association between employment levels and CD4 counts among
adults taking ART. Adults with CD4>200 had better employment outcomes, although the
sample size of those with CD4≥500 was limited. These findings are consistent with the
restorative effects of ART on employment outcomes identified in other studies [1, 2, 6] as
well as decreases in food insecurity following ART initiation near this study setting.[17]
However, controlling for CD4 count, those on ART had lower employment than those not
on ART. Explanations for this finding include the possibility that those on ART experienced
a decline in economic status prior to ART initiation that may be difficult to recover from
completely, but also that ART dampens productivity to some degree by necessitating time
off work to attend clinic appointments.
Higher CD4 counts among adults were also associated with better educational outcomes for
the children living with those adults, particularly those between 12–18 years of age. But due
to the small sample size of children in households of HIV-infected adults, these differences
were not statistically significant. The effect on older children is consistent with the
hypothesis that children with higher labor productivity are most likely to be diverted away
from school and into the labor force when the health of an adult deteriorates.
Several limitations of this study should be emphasized. First, the cross-sectional and non-
experimental study design limits our ability to draw causal inferences. A particular concern
is that the results from comparing adults who are not on ART and have high vs. low CD4
counts may be biased because those who with low CD4 counts may have characteristics
(such as high discount rates) that also cause them to have low employment levels.
Longitudinal data would enable us to better identify the period during HIV infection when
socio-economic outcomes begin to deteriorate. A second limitation stems from the relatively
small sample size of HIV-infected adults in the study. This led us to examine the association
between fewer categorical ranges of CD4 count than would have been possible with a larger
sample size. Moreover, we were unable to detect statistically significant differences in
employment outcomes among those with CD4≥200. For example, although HIV-infected
adults with CD4≥500 worked more days/month than adults with CD4 200–349 and CD4
350–499, there was insufficient power to detect a significant effect. Future attempts to
implement community-wide HIV testing campaigns in a greater number of regions can help
overcome this limitation. Finally, while we did not observe differences in the CD4-
employment association between men and women, it should be noted that men were less
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likely to participate in the campaign than women.[13] The generalizability of the results may
thus be greater among women, as it is possible that healthier, more productive men were less
likely to attend the campaign. Future campaigns in the study area will pilot strategies to
increase men’s participation, which would enable us to test whether the association between
health status and employment is markedly different from the current findings.
Our findings from a community health campaign that included HIV-infected adults who had
not been diagnosed previously show that socio-economic outcomes are better among those
with CD4 counts that are well above the thresholds at which ART is typically initiated in
Uganda and other resource-limited settings. This suggests that early ART initiation may
keep employment and schooling outcomes at levels similar to those of HIV-uninfected
adults and households. However, due to the cross-sectional analyses and the small sample
size of the study, the results presented here do not allow us to identify the CD4 threshold at
which ART initiation would generate such benefits. Randomized controlled trials of early
ART initiation, combined with socio-economic data, will be useful for determining the size
of these benefits.
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Figure 1. Nonparametric regression results showing association between employment outcomes
and CD4 cell counts among HIV-infected adults not on ART
Notes
Results from estimating kernel-weighted local polynomial regression with width of 100
cells/μL around each point and 50 points at which relationship is evaluated. Vertical axis
displays the number of days worked in the past month, while the horizontal axis displays the
CD4 cell count.
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Table 1
Characteristics of adult campaign participants
Variable HIV− HIV+ P-value1
N 2,103 179
With CD4 count 168
Female 65% 77% <0.01
Age 39.5 33.2 <0.01
Married 67% 58% 0.01
Above primary education 20% 18% 0.52
Above secondary education 4% 4% 0.93
Household size 6.1 4.7 <0.01
Number of children 2.7 1.9 <0.01
# acres of land owned 4.4 2.5 <0.01
# acres ≥ 1 88% 72% <0.01
# of cows owned 2.4 0.6 <0.01
# cows ≥ 1 0.3 0.1 <0.01
# of poultry owned 2.5 1.8 0.07






p-values from comparison of HIV− and HIV+ adults using chi-squared tests for categorical variables and t-tests for continuous variables.
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Table 4
Association between employment outcomes and CD4 count, by ART status
(1) (2) (3) (4)
 Outcome: Days worked in the past month Hours worked on usual day in past week
Sample: Not on ART On ART Not on ART On ART
Female −24.84 (19.26) −61.31** (26.49) −8.78 (8.22) −7.27 (9.07)
Age (years) −0.44 (0.85) −2.09** (1.0) −0.14 (0.36) 0.05 (0.34)
Age squared 0.01 (0.01) 0.02** (0.01) 0.002 (0.004) −0.000 (0.004)
Female * Age 1.52 (0.92) 3.18** (1.25) 0.44 (0.40) 0.34 (0.43)
Female * Age squared −0.02** (0.01) −0.04** (0.01) −0.01 (0.004) −0.004 (0.01)
CD4 <200 Reference Reference Reference Reference
CD4 200–349 3.31 (2.74) 4.15 (3.80) 2.01* (1.17) 2.50* (1.30)
CD4 350–499 5.83** (2.92) 6.91* (3.66) 1.29 (1.25) 0.53 (1.25)
CD4 ≥500 6.86*** (2.59) 5.23 (3.48) 2.53** (1.11) 1.59 (1.19)
Constant 22.85 (18.0) 56.61*** (20.94) 9.12 (7.68) 3.76 (7.17)
Observations 107 60 107 60
P-values for post-estimation estimation Wald tests
CD4 350–499 = CD4 200–349 0.33 0.41 0.51 0.10
CD4≥500 = CD4 200–349 0.10 0.71 0.58 0.37
CD4≥500 = CD4 350–499 0.67 0.57 0.24 0.30
Notes





Columns 1 and 2 report results from regression models that have “days worked in the past month” as the outcome variable. Columns 3 and 4 report
results from regression models that have “hours worked on a typical day in the past week” as the outcome variable. In columns 1 and 3, the sample
is restricted to HIV-infected adults not on ART. In columns 2 and 4, the sample is restricted to HIV-infected adults on ART. The reference group
for the CD4 categories is CD4<200.
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Table 5
Association between child school enrollment and CD4 count of adult
(1) (2) (3) (4)
Outcome: Enrolled in school
Sample: Age 6–18 Age 6–18 Age 6–11 Age 12–18
Male −0.01 (0.05) −0.003 (0.05) 0.06 (0.04) −0.05 (0.08)
Age (years) 0.13** (0.05) 0.12** (0.05) 0.22 (0.18) −0.20 (0.36)
Age squared −0.01*** (0.002) −0.01*** (0.002) −0.01 (0.01) 0.004 (0.01)
CD4 count (units of 100) 0.01 (0.01)
CD4<350 - Reference Reference Reference
CD4 =350 - 0.07 (0.056) 0.04 (0.05) 0.10 (0.08)
Observations 107 107 50 57
Notes





The reference group for the CD4≥350 is CD4<350.
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